Palbociclib and Binimetinib in RAS-Mutant Cancers: A ComboMATCH Treatment Trial
(See required screening study ECOG-ACRIN EAY191)
EAY191-A3, Cohort 4 is temporarily closed to accrual effective September 5, 2024.
EAY191-A3, Cohort 3 is temporarily closed to accrual effective July 3, 2024.